![](https://www.precisionvaccinations.com/sites/default/files/styles/article_metadata/public/Screenshot%202024-07-29%2010.01.04%20AM.png)
$3 Million Grant Supports Bi-Specific Malaria Vaccine Development
(Precision Vaccinations News)Versatope Therapeutics Incorporated announced today it has received a Phase 2 Small Business Innovation Research (SBIR) grant for up to $3 million over three years from the U.S. NIH's National Institute of Allergy and …